A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...

We recently published a list of Jim Cramer Says Trump’s Tariff Strategy Is Working & Discusses These 11 Stocks. In this ...

Discover predictions for upcoming dividend increases from top companies with long-term growth. Learn which stocks to watch ...

A unit of medical group Johnson & Johnson (JNJ) has been ordered to pay $1.64 billion for illegally promoting the HIV drugs Prezista and ...

Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.

Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...

We recently published a list of Jim Cramer Focused On These 9 Stocks Recently. In this article, we are going to take a look ...

Johnson & Johnson said it is increasing U.S investments to more than $55 billion over the next four years, boosting spending ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) has received a consensus rating of “Moderate Buy” from the eighteen research ...

American pharmaceutical giant Johnson & Johnson (JNJ) is boosting its U.S. investments by 25% to more than $55 billion over ...

Buy, Hold or Sell Johnson & Johnson? View our complete analysis and fair value estimate and you decide. NYSE:JNJ Earnings Per Share Growth as at Mar 2025 Find companies with promising cash flow ...

Johnson & Johnson (NYSE:JNJ) experienced an 11% price increase over the last quarter. This movement coincided with several ...